Authors
Latest:
FDA Approves Nasal Spray Treatment for MigraineThe FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.
Latest:
Real-World Dosing and Utilization of Ustekinumab Among Patients With PsoriasisThis study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
PLEI Perspectives: Will the Real Leaders Please Stand and Be Recognized?Those who think that leadership is only about a title held by a select few are sadly mistaken.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
What You Need to Know About Probiotics in Your DietHaving a healthy gut with the right balance of good bacteria may change the entire health of our bodies.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
Trending News Today: Support for the ACA Hits All-Time HighTop news of the day from across the health care landscape.
Latest:
Advisory Committee on Immunization Practices Issues Interim Recommendation for Janssen's COVID-19 VaccineACIP issued an interim recommendation to the Janssen COVID-19 vaccine for use in individuals aged ≥18 years for the prevention of COVID-19.
Latest:
Visual Impairment May Be Early Risk Factor for DementiaAlthough there is no underlying mechanism specifically associating cognitive and visual impairment, the investigators noted that the relationship between cognitive and visual function is likely bidirectional and multifactorial.
Latest:
Expanding Pharmacy's ReachJeffrey Gower's varied experience includes developing innovative diabetes programs and working with the Indian Health Service.
Latest:
Bringing an Interprofessional Dimension to Pharmacy EducationPharmacy is part of an ever-changing set of health care professions to which we must learn to adapt quickly, both now and over the course of our careers.
Latest:
Work Productivity Associated With Treated Versus Never-Treated Overactive Bladder SymptomsOveractive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.
Latest:
Supreme Court Rules Pay-to-Delay Agreements Can Be ChallengedThe court's decision makes it more likely that generic versions of medications will be made available before their patents expire and will likely lead to reduced drug costs for consumers.
Latest:
Are Pharmacy Schools Growing Too Fast?Pharmacy schools have been growing at an unprecedented rate, and if the trend continues as expected it could pose problems for the future success of the profession.
Latest:
Cardiovascular Risk Reduction in the Workforce: Optimizing Cholesterol Management to Reduce the Burden of Cardiovascular DiseaseInvestment in prevention and treatment of cardiovascular disease must consider overall effect on employee health and productivity, not exclusively direct health coverage costs.
Latest:
My Care Team, My Prerogative: It's Time to Plug inKeeping up with the latest connectivity options has become an essential task for pharmacists as health care migrates from paper to electronic systems.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Challenges, Opportunities Mark Health Care Landscape in 2022Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend
Latest:
Impact of HIE Drug Formularies on Patient Out-of-Pocket CostsBenefit structure and formulary design characteristics are important for individuals with high out-of-pocket costs in federally facilitated Health Insurance Exchanges.
Latest:
GlaxoSmithKline and Human Genome Sciences, Inc's BenlystaThs FDA approved Benlysta (belimumab) for the treatment of adults with active, autoantibody- positive systemic lupus.
Latest:
Bring Your Own Weather: How Your Attitude Affects OthersHow much do your actions affect those around you? Read here to learn about how to consciously change your environment.
Latest:
Opioid Overdose and Naloxone Delivery Devices in the Community SettingAlthough naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Latest:
Practice Pearl: Envisioning Your FutureAn evolving pharmacy practice started with the the owners' vision, and worked backwards to become a reality.
Latest:
Historic Trends Provide Context to 2016 NAPLEX and MPJE Performance DataEnsuring that the North American Pharmacist Licensure Examination and the Multistate Pharmacy Jurisprudence Examination accurately measure the competence of candidates seeking licensure is of the utmost importance to the boards of pharmacy and the National Association of Boards of Pharmacy.
Latest:
USP Workshop Examines Ways to Improve Medicines Quality in Asia-Pacific RegionThe U.S. Pharmacopeial Convention (USP) is bringing together national medicines control laboratory officials, as part of ongoing efforts to strengthen regional cooperation for improved medicines quality in the Asia-Pacific region.
Latest:
Will Biosimilars be the Future of Specialty Pharmacy?Biosimilars present a cost-saving opportunity for the health care system, but significant challenges inhibit uptake in the US market.
